Pharmaxis Files Aust Marketing Application for Bronchitol – Sydney Morning Herald
Pharmaxis Files Aust Marketing Application for Bronchitol Sydney Morning Herald, Australia - 2 hours ago obstructive pulmonary disease (COPD), PXS25 for the treatment of lung fibrosis and PXS4159 for asthma. (symbol PXSL). The company is headquartered in Sydney ... |